New treatment option available for Dravet syndrome
Global biopharma company UCB says the UK’s National Institute for Healthcare Excellence (NICE) has issued…
June 1, 2022 - 3 minutes
Global biopharma company UCB says the UK’s National Institute for Healthcare Excellence (NICE) has issued…